Medtech1.com: Great Information, Real Community, Better Living.
 Register
 Login
 Main Page
 MedTech News
Tech & Innovation
Living With a Device
 Education Center
Diagnostic Tests
Conditions
Procedures
Women's Health
Companies
Online Resources
Video Library
Dr. Christopher Kwolek  MedTech  Hero™
Dr. Christopher Kwolek:
Pioneering New Blood Clot Treatments.
About Heroes
 Join the Discussion in  Our Forums
 Community
MedTech1 Forums
 Advocacy Center
Contact Congress
Find a Patient Group
 Bookmark Us
 
advertisement
Search the Body1 Network
August 08, 2020  
MEDTECH NEWS: Technology & Innovation

  • Print this Article
  • Email this Article
  • Links/Reprints
  • Cancer Nanotechnology: A New Frontier

    Cancer Nanotechnology: A New Frontier


    May 21, 2007

    By: Erin Moore for Medtech1

    Researchers around the country are focusing on a novel method of cancer detection and treatment: nanotechnology. Most people are unaware of this exciting new field of study because it is in the pre-clinical phase; in other words, it has not reached human trials as of yet. While nanotechnology holds promise for a number of disease states, cancer is one of the areas in which positive results have occurred.

    Sadly, some cancers are multi-drug resistant (MDR). That is, they do not respond to any available type of drug therapy. Sometimes cancers are MDR on first diagnosis, and more commonly they are MDR if and when they recur. Scientists have identified two reasons why this may be so: poor drug delivery and cellular resistance. Currently, chemotherapy is administered via liquid infusion. Nanoparticles, on the other hand, are microscopic crystals that have effectively delivered higher levels of drug to tumor in animal models. Not only can these nanoparticles load 10 to 100 times more drug into the tumor site, but they can deliver the drug in a targeted manner. The particle is constructed so that it travels through the body and only dissolves, releasing the drug, once it reaches the affected area. This breakthrough also means that side effects are significantly reduced, because healthy tissue is not subject to drug effects. In animal studies, treatment via nanoparticles led to higher drug concentrations throughout tumors as well as significantly greater tumor suppression than with standard drug delivery methods.

    To learn more about nanotechnology for the early diagnosis and treatment of cancer, visit the National Cancer Institute’s Alliance for Nanotechnology in Cancer Web site here.

    Source: Mansoor Amiji, Northeastern University, and Omid Farokhzad, Harvard University, BIO Conference 2007.

    Last updated: 21-May-07

    Comments

  • Add Comment
  •    
    Interact on Medtech1

    Discuss this topic with others.
     
    Feature Archives

    Web Technology to Offer Further Mental Health Support

    Sweat Powers Tattoo Biobatteries While You Exercise

    Activity Trackers Could be Beneficial for Older Adults

    Diseases Diagnosed by 'Smart' Holograms

    Fruit flies make good stand-ins for humans in diabetes treatment tests

    Next 5 Features ...

    More Features ...
       
     
    Related Multimedia

    Interview with Dr. Chen: Gastrointestinal Cancer - Staging Cancer

    Interview with Dr. Chen - Gerd and Gastroenterology

     
    Related Content
    Undertreatment of Breast Cancer in Obese Women May Be Detrimental

    Tuberculosis

    Testicular Cancer

    Cervical Cancer

    Ovarian Cancer

    More Features ...
     
    Home About Us Press Jobs Advertise With Us Contact Us
    advertisement
    © 2020 Body1 All rights reserved.
    Disclaimer: The information provided within this website is for educational purposes only and is not a substitute for consultation with your physician or healthcare provider. The opinions expressed herein are not necessarily those of the Owners and Sponsors of this site. By using this site you agree to indemnify, and hold the Owners and Sponsors harmless, from any disputes arising from content posted here-in.